We are live on
!
Find out more
PHS
PFM Health Sciences Portfolio holdings
AUM
$1.1B
1-Year Est. Return
57.92%
This Fund
S&P 500
This Quarter
Est. Return
+32.65%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$2.1B
AUM Growth
-$1.29B
(-38%)
Cap. Flow
-$1.61B
Cap. Flow
% of AUM
-76.67%
Top 10 Holdings %
Top 10 Hldgs %
43.41%
Holding
94
New
23
Increased
6
Reduced
30
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$63.4M |
| 2 |
Elevance Health
ELV
|
+$54.6M |
| 3 |
Centene
CNC
|
+$44.4M |
| 4 |
Pfizer
PFE
|
+$34.7M |
| 5 |
ICU Medical
ICUI
|
+$28.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$121M |
| 2 |
Penumbra
PEN
|
+$97.1M |
| 3 |
Zimmer Biomet
ZBH
|
+$77.5M |
| 4 |
NXP Semiconductors
NXPI
|
+$75.2M |
| 5 |
Microchip Technology
MCHP
|
+$72.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 69.54% |
| 2 | Technology | 2.78% |
| 3 | Consumer Discretionary | 0.53% |
| 4 | Financials | 0.1% |
| 5 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
NXP Semiconductors
NXPI
$57.8B
| $7.92M | 0.38% |
62,249
-647,681
| -91% | -$75.2M |
|
|
XYZ
52
Block Inc
XYZ
$48.4B
| $5.03M | 0.24% |
+80,427
| New | +$5.14M |
|
53
Intuit
INTU
$86.5B
| $4.39M | 0.21% |
16,747
-163,355
| -91% | -$42.7M |
|
|
ACOR
54
DELISTED
Acorda Therapeutics
ACOR
| $3.86M | 0.18% |
15,778
-2,441
| -13% | -$616K |
|
55
PayPal
PYPL
$48.9B
| $2.06M | 0.1% |
19,076
+3,840
| +25% | +$400K |
|
56
Visteon
VC
$2.79B
| $1.76M | 0.08% |
20,313
-129,271
| -86% | -$11.5M |
|
|
COUP
57
DELISTED
Coupa Software Incorporated
COUP
| $1.42M | 0.07% |
9,731
-157,592
| -94% | -$22.5M |
|
|
ELGX
58
DELISTED
Endologix Inc
ELGX
| $252K | 0.01% |
159,285
-94,605
| -37% | -$265K |
|
59
Advanced Micro Devices
AMD
$776B
| – | – |
-890,079
| Closed | -$25.8M |
|
60
DexCom
DXCM
$32.2B
| – | – |
-1,712,968
| Closed | -$63.9M |
|
61
Equillium
EQ
$139M
| – | – |
-1,064,979
| Closed | -$4.05M |
|
62
Fate Therapeutics
FATE
$286M
| – | – |
-881,002
| Closed | -$13.7M |
|
63
GoDaddy
GDDY
$11B
| – | – |
-723,756
| Closed | -$47.8M |
|
64
Goldman Sachs
GS
$300B
| – | – |
-47,320
| Closed | -$9.81M |
|
65
Inspire Medical Systems
INSP
$1.45B
| – | – |
-350,870
| Closed | -$21.4M |
|
66
Live Nation Entertainment
LYV
$40.5B
| – | – |
-197,341
| Closed | -$13.1M |
|
67
CALL
McKesson
MCK
$100B
| – | – |
-167,400
| Closed | -$22.9M |
|
68
MKS Inc
MKSI
$20.1B
| – | – |
-301,611
| Closed | -$27.8M |
|
69
Puma Biotechnology
PBYI
$404M
| – | – |
-3,689,538
| Closed | -$39.7M |
|
70
PTC Therapeutics
PTCT
$5.64B
| – | – |
-1,654,225
| Closed | -$55.9M |
|
71
uniQure
QURE
$3.03B
| – | – |
-1,158,694
| Closed | -$45.6M |
|
|
SAGE
72
DELISTED
Sage Therapeutics
SAGE
| – | – |
-373,828
| Closed | -$52.4M |
|
73
Stryker
SYK
$125B
| – | – |
-207,887
| Closed | -$45M |
|
74
Tradeweb Markets
TW
$21.4B
| – | – |
-67,157
| Closed | -$2.48M |
|
75
Twilio
TWLO
$30B
| – | – |
-534,889
| Closed | -$58.8M |
|
Similar funds
DAM
MAM
LCM
DAM
KCM
CF
MIA
YL
PFM Health Sciences's Q4 2019 Portfolio in Review
As of Q4 2019, PFM Health Sciences held 94 positions worth $2.1B, down 38% from $3.39B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
PFM Health Sciences withdrew a net $1.61B in Q4 2019, closing 33 positions and reducing 30 holdings. Its most notable exit was Wellcare Health Plans, Inc., an estimated $68.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 70% of assets, up from 60% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, PFM Health Sciences opened a new position in Biogen worth $67.8M.
- PFM Health Sciences's largest Q4 2019 buy was Biogen: 228,328 shares worth $67.8M.
- PFM Health Sciences added most to NEVRO CORP. in Q4 2019, an estimated $17.9M increase.
- PFM Health Sciences's biggest Q4 2019 reduction was BioMarin Pharmaceuticals, cutting an estimated $121M.
- PFM Health Sciences fully exited Wellcare Health Plans, Inc. in Q4 2019, selling an estimated $68.3M.
- PFM Health Sciences's ten largest holdings make up 43% of its $2.1B portfolio in Q4 2019.
- PFM Health Sciences opened 23 new positions and closed 33 in Q4 2019.
- PFM Health Sciences's portfolio value fell 38% quarter-over-quarter to $2.1B.
Based on PFM Health Sciences's 13F filing for Q4 2019, filed 14 Feb 2020.